![Barbara Duncan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barbara Duncan
Directeur/Membre du Conseil chez
HALOZYME THERAPEUTICS, INC.
Fortune : 2 M $ au 30/06/2026
Profil
Barbara Gayle Duncan currently works at Halozyme Therapeutics, Inc., as Independent Director from 2023, Atea Pharmaceuticals, Inc., as Independent Director from 2020, Ovid Therapeutics, Inc., as Independent Director from 2017, Halozyme, Inc., as Director from 2023, and Versanis Bio, Inc., as Non-Executive Director from 2022.
Ms. Duncan also formerly worked at Fusion Pharmaceuticals, Inc., as Chairman from 2020 to 2024, Immunomedics, Inc., as Independent Director from 2019 to 2020, DOV Pharmaceutical, Inc., as Chief Executive & Financial Officer, Director from 2007 to 2009, Edgemont Pharmaceuticals LLC, as Director, SBC Warburg Dillon Read Corporate Finance AG, as Director-Corporate Finance from 1994 to 1998, Innoviva, Inc., as Director from 2016 to 2018, Aevi Genomic Medicine, Inc., as Independent Director from 2015 to 2020, Adaptimmune Ltd., as Non-Executive Director, Jounce Therapeutics, Inc., as Independent Director from 2016 to 2023, ObsEva SA, as Independent Director from 2016 to 2021, Adaptimmune Therapeutics Plc, as Independent Non-Executive Director from 2016 to 2023, Lehman Brothers, Inc., as Vice President-Corporate Finance Division in 2001, PepsiCo, Inc., as International Auditor from 1989 to 1992, Intercept Pharmaceuticals, Inc., as Chief Financial Officer, Secretary & Treasurer from 2010 to 2016, and Deloitte & Touche LLP, as Senior Accountant from 1986 to 1989.
Ms. Duncan received her undergraduate degree in 1985 from Louisiana State University and Masters Business Admin degree in 1994 from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/05/2026 | 19 919 ( 0,02% ) | 2 M $ | 30/06/2026 | |
| 18/06/2026 | 92 350 ( 0,12% ) | 429 428 $ | 30/06/2026 | |
| 17/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Barbara Duncan
| Sociétés | Poste | Début |
|---|---|---|
| OVID THERAPEUTICS INC. | Directeur/Membre du Conseil | 14/06/2017 |
| ATEA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/10/2020 |
| HALOZYME THERAPEUTICS, INC. | Directeur/Membre du Conseil | 03/02/2023 |
Versanis Bio, Inc.
 Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Directeur/Membre du Conseil | 20/07/2022 |
Halozyme, Inc.
 Halozyme, Inc. BiotechnologyHealth Technology Part of Halozyme Therapeutics, Inc., Halozyme, Inc. is a company based in San Diego, CA. | Directeur/Membre du Conseil | 01/02/2023 |
Anciens postes connus de Barbara Duncan
| Sociétés | Poste | Fin |
|---|---|---|
| FUSN PHAR | Président | 04/06/2024 |
| ADAPTIMMUNE THERAPEUTICS PLC | Directeur/Membre du Conseil | 01/06/2023 |
| JOUNCE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 03/05/2023 |
| OBSEVA SA | Directeur/Membre du Conseil | 28/05/2021 |
| ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Barbara Duncan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
PepsiCo, Inc.
 PepsiCo, Inc. Food: Specialty/CandyConsumer Non-Durables Makes, markets, distributes and sells beverages & convenient food products | Consumer Non-Durables |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
DOV Pharmaceutical, Inc.
 DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops novel drugs | Commercial Services |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Edgemont Pharmaceuticals LLC
 Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Health Technology |
Atea Pharmaceuticals, Inc.
 Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
Ovid Therapeutics, Inc.
 Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
SBC Warburg Dillon Read Corporate Finance AG
 SBC Warburg Dillon Read Corporate Finance AG Investment Banks/BrokersFinance Provides investment banking services | Finance |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Louisiana State University
 Louisiana State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of treatments for auto-immune pediatric disease | Health Technology |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Focuses on the use of T cell therapy to treat cancer and infectious diseases | Health Services |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
Halozyme, Inc.
Halozyme, Inc. BiotechnologyHealth Technology Part of Halozyme Therapeutics, Inc., Halozyme, Inc. is a company based in San Diego, CA. | Health Technology |
ObsEva SA
 ObsEva SA Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments to increase women's reproductivity | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
